Marinomed Biotech AG
MARI | VI
Overview
Corporate Details
- ISIN(s):
- ATMARINOMED6
- LEI:
- 529900GN3B1EN80XF405
- Country:
- Austria
- Address:
- Hovengasse 25, 2100 Korneuburg
- Website:
- https://www.marinomed.com/en
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Marinomed Biotech AG is an Austrian, science-based biotech company with a growing development pipeline and globally marketed therapeutics. The Company develops innovative patent-protected products in the therapeutic areas immunology and virology based on the platform Marinosolv® and the virus-blocking activity of iota-carrageenan. The Marinosolv® technology improves the solubility and bioavailability of hardly soluble compounds and is used to develop new therapeutics for autoreactive immune disorders. The virology segment includes Carragelose®-based over-the-counter (OTC) products to prevent and treat respiratory viral infections that are partnered in more than 40 countries. Marinomed also develops drugs for other serious viral infectious diseases based on iota carrageenan.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-06 15:20 |
Regulatory News Service
Marinomed Biotech AG announces partnership for Budesolv in Switzerland
|
English | 8.2 KB | |
| 2025-06-04 09:32 |
Declaration of Voting Results & Voting Rights Announcements
EQS-PVR: Marinomed Biotech AG: Release according to Article 135, Section 2 Börs…
|
English | 31.6 KB | |
| 2025-06-04 09:31 |
Declaration of Voting Results & Voting Rights Announcements
EQS-PVR: Marinomed Biotech AG: Veröffentlichung gemäß § 135 Abs. 2 BörseG mit d…
|
German | 31.9 KB | |
| 2025-06-04 09:30 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 12.1 KB | |
| 2025-06-04 09:29 |
Declaration of Voting Results & Voting Rights Announcements
EQS-PVR: Marinomed Biotech AG: Release according to Article 135, Section 2 Börs…
|
English | 31.6 KB | |
| 2025-06-04 09:29 |
Declaration of Voting Results & Voting Rights Announcements
EQS-PVR: Marinomed Biotech AG: Veröffentlichung gemäß § 135 Abs. 2 BörseG mit d…
|
German | 31.9 KB | |
| 2025-05-14 10:01 |
General Meeting Notice
EQS-AGM: Supplemented Version of the Convocation published on May 12, 2025 for …
|
English | 50.4 KB | |
| 2025-05-14 10:01 |
General Meeting Notice
EQS-HV: Ergänzte Fassung der am 12. Mai 2025 veröffentlichten Einberufung der 8…
|
German | 45.1 KB | |
| 2025-05-14 10:00 |
General Meeting Notice
Supplemented Version of the Convocation published on May 12, 2025 for the 8th A…
|
English | 22.0 KB | |
| 2025-05-12 11:25 |
General Meeting Notice
Marinomed Biotech AG: Invitation to the 8th Annual General Meeting on Wednesday…
|
English | 21.7 KB | |
| 2025-05-08 09:20 |
Earnings Release
Marinomed Biotech AG announces results for the first quarter of 2025
|
English | 12.1 KB | |
| 2025-04-16 07:48 |
Annual Report
EQS-AFR: Marinomed Biotech AG: Release of a Financial report
|
English | 5.5 MB | |
| 2025-04-16 07:48 |
Annual Report (ESEF)
EQS-AFR: Marinomed Biotech AG: Bekanntmachung über die Veröffentlichung eines F…
|
German | 2.1 MB | |
| 2025-04-16 07:47 |
Annual Report
EQS-AFR: Marinomed Biotech AG: Bekanntmachung über die Veröffentlichung eines F…
|
German | 5.5 MB | |
| 2025-04-16 07:45 |
Report Publication Announcement
|
English | 3.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |